Skip to main content
Top
Published in: Annals of Hematology 11/2017

01-11-2017 | Original Article

A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation

Authors: Tomoko Sato, Takaaki Konuma, Yoriko Miwa, Nozomi Sugihara, Yukari Tsuru, Hatsuko Narita, Satomi Kiriyama, Seiko Kato, Maki Oiwa-Monna, Koji Kobayashi, Satoshi Takahashi, Arinobu Tojo

Published in: Annals of Hematology | Issue 11/2017

Login to get access

Abstract

Taste disorders are one of the most common complications in patients undergoing allogeneic hematopoietic cell transplantation (HCT). They persist in some patients as a late complication 3 months or more after HCT. Therefore, we conducted a cross-sectional study to evaluate the prevalence and predictive factors of late taste disorders, with the help of a self-reporting and closed-ended questionnaire, which was distributed among 91 patients in our institute. The median age at this study was 50 (range, 25–69) years. The median follow-up period was 54 (range, 3–234) months after HCT. Taste disorders were observed in 43 patients (47%). The most frequent form of late taste disorders was reduced appetite in 18 patients (20%). The most frequent form of decline of basic taste was umami, which was observed in 12 patients (13%). Almost all taste disorders were mild in their severity. Multivariate logistic regression analyses showed that the duration of less than 1 year post HCT and the presence of oral chronic graft-versus-host disease are important risk factors for late taste disorders in survivors of HCT. These data suggested that taste disorders usually return to normal levels more than a year after HCT in most recipients.
Literature
1.
go back to reference Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087CrossRefPubMed Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087CrossRefPubMed
2.
go back to reference Gamper EM, Zabernigg A, Wintner LM, Giesinger JM, Oberguggenberger A, Kemmler G et al (2012) Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manag 44:880–895CrossRef Gamper EM, Zabernigg A, Wintner LM, Giesinger JM, Oberguggenberger A, Kemmler G et al (2012) Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manag 44:880–895CrossRef
3.
4.
go back to reference Boer CC, Correa ME, Miranda EC, de Souza CA (2010) Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant 45:705–711CrossRefPubMed Boer CC, Correa ME, Miranda EC, de Souza CA (2010) Taste disorders and oral evaluation in patients undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant 45:705–711CrossRefPubMed
5.
go back to reference Marinone MG, Rizzoni D, Ferremi P, Rossi G, Izzi T, Brusotti C (1991) Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients. Haematologica 76:519–522PubMed Marinone MG, Rizzoni D, Ferremi P, Rossi G, Izzi T, Brusotti C (1991) Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients. Haematologica 76:519–522PubMed
6.
go back to reference Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringdén O (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21:33–37CrossRefPubMed Mattsson T, Arvidson K, Heimdahl A, Ljungman P, Dahllof G, Ringdén O (1992) Alterations in taste acuity associated with allogeneic bone marrow transplantation. J Oral Pathol Med 21:33–37CrossRefPubMed
7.
go back to reference Majorana A, Amadori F, Bardellini E, Campus G, Conti G, Strohmenger L et al (2015) Taste dysfunction in patients undergoing hematopoietic stem cell transplantation: clinical evaluation in children. Pediatr Transplant 19:571–575CrossRefPubMed Majorana A, Amadori F, Bardellini E, Campus G, Conti G, Strohmenger L et al (2015) Taste dysfunction in patients undergoing hematopoietic stem cell transplantation: clinical evaluation in children. Pediatr Transplant 19:571–575CrossRefPubMed
8.
go back to reference Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785–792CrossRefPubMed Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785–792CrossRefPubMed
9.
go back to reference Kano T, Kanda K (2013) Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40:E79–E85CrossRefPubMed Kano T, Kanda K (2013) Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 40:E79–E85CrossRefPubMed
10.
go back to reference Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367–369CrossRefPubMedPubMedCentral Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 15:367–369CrossRefPubMedPubMedCentral
11.
go back to reference Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956CrossRefPubMed Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945–956CrossRefPubMed
12.
go back to reference Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed
13.
go back to reference Shi HB, Masuda M, Umezaki T, Kuratomi Y, Kumamoto Y, Yamamoto T et al (2004) Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx 31:401–406CrossRefPubMed Shi HB, Masuda M, Umezaki T, Kuratomi Y, Kumamoto Y, Yamamoto T et al (2004) Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx 31:401–406CrossRefPubMed
14.
go back to reference Turcott JG, Juárez-Hernández E, De la Torre-Vallejo M, Sánchez-Lara K, Luvian-Morales J, Arrieta O (2016) Changes in the detection and recognition thresholds of three basic tastes in lung cancer patients receiving cisplatin and paclitaxel and its association with nutritional and quality of life parameters. Nutr Cancer 68:241–249CrossRefPubMed Turcott JG, Juárez-Hernández E, De la Torre-Vallejo M, Sánchez-Lara K, Luvian-Morales J, Arrieta O (2016) Changes in the detection and recognition thresholds of three basic tastes in lung cancer patients receiving cisplatin and paclitaxel and its association with nutritional and quality of life parameters. Nutr Cancer 68:241–249CrossRefPubMed
15.
go back to reference Tsutsumi R, Goda M, Fujimoto C, Kanno K, Nobe M, Kitamura Y et al (2016) Effects of chemotherapy on gene expression of lingual taste receptors in patients with head and neck cancer. Laryngoscope 126:E103–E109CrossRefPubMed Tsutsumi R, Goda M, Fujimoto C, Kanno K, Nobe M, Kitamura Y et al (2016) Effects of chemotherapy on gene expression of lingual taste receptors in patients with head and neck cancer. Laryngoscope 126:E103–E109CrossRefPubMed
16.
go back to reference Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L et al (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031–1035CrossRefPubMed Lilleby K, Garcia P, Gooley T, McDonnnell P, Taber R, Holmberg L et al (2006) A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 37:1031–1035CrossRefPubMed
17.
go back to reference Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D et al (2017) Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. Bone Marrow Transplant 52:154–156CrossRefPubMed Marchesi F, Tendas A, Giannarelli D, Viggiani C, Gumenyuk S, Renzi D et al (2017) Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study. Bone Marrow Transplant 52:154–156CrossRefPubMed
18.
go back to reference Okada N, Hanafusa T, Abe S, Sato C, Nakamura T, Teraoka K et al (2016) Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention. Support Care Cancer 24:3979–3985CrossRefPubMed Okada N, Hanafusa T, Abe S, Sato C, Nakamura T, Teraoka K et al (2016) Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention. Support Care Cancer 24:3979–3985CrossRefPubMed
Metadata
Title
A cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation
Authors
Tomoko Sato
Takaaki Konuma
Yoriko Miwa
Nozomi Sugihara
Yukari Tsuru
Hatsuko Narita
Satomi Kiriyama
Seiko Kato
Maki Oiwa-Monna
Koji Kobayashi
Satoshi Takahashi
Arinobu Tojo
Publication date
01-11-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3087-6

Other articles of this Issue 11/2017

Annals of Hematology 11/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.